Segelmark M - Search Results

1

Incidence and survival rates in Wegener's granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and polyarteritis nodosa.

Mohammad AJ, Jacobsson LT, Westman KW, Sturfelt G, Segelmark M. Mohammad AJ, et al. Among authors: segelmark m. Rheumatology (Oxford). 2009 Dec;48(12):1560-5. doi: 10.1093/rheumatology/kep304. Epub 2009 Oct 1. Rheumatology (Oxford). 2009. PMID: 19797309

2

Clinical evaluation of a capture ELISA for detection of proteinase-3 antineutrophil cytoplasmic antibody.

Westman KW, Selga D, Bygren P, Segelmark M, Baslund B, Wiik A, Wieslander J. Westman KW, et al. Among authors: segelmark m. Kidney Int. 1998 May;53(5):1230-6. doi: 10.1046/j.1523-1755.1998.00873.x. Kidney Int. 1998. PMID: 9573537 Free article.

3

C3 and C4 allotypes in anti-neutrophil cytoplasmic autoantibody (ANCA)-positive vasculitis.

Persson U, Truedsson L, Westman KW, Segelmark M. Persson U, et al. Among authors: segelmark m. Clin Exp Immunol. 1999 May;116(2):379-82. doi: 10.1046/j.1365-2249.1999.00889.x. Clin Exp Immunol. 1999. PMID: 10337034 Free PMC article.

4

Recurrent ANCA-associated small vessel vasculitis after transplantation: A pooled analysis.

Nachman PH, Segelmark M, Westman K, Hogan SL, Satterly KK, Jennette JC, Falk R. Nachman PH, et al. Among authors: segelmark m. Kidney Int. 1999 Oct;56(4):1544-50. doi: 10.1046/j.1523-1755.1999.00666.x. Kidney Int. 1999. PMID: 10504506 Free article.

5

How and why should we detect ANCA?

Segelmark M, Westman K, Wieslander J. Segelmark M, et al. Clin Exp Rheumatol. 2000 Sep-Oct;18(5):629-35. Clin Exp Rheumatol. 2000. PMID: 11072609 Review.

6

Increased monocyte transcription of the proteinase 3 gene in small vessel vasculitis.

Ohlsson S, Hellmark T, Pieters K, Sturfelt G, Wieslander J, Segelmark M. Ohlsson S, et al. Among authors: segelmark m. Clin Exp Immunol. 2005 Jul;141(1):174-82. doi: 10.1111/j.1365-2249.2005.02819.x. Clin Exp Immunol. 2005. PMID: 15958084 Free PMC article.

7

Polyarteritis nodosa when applying the Chapel Hill nomenclature--a descriptive study on ten patients.

Selga D, Mohammad A, Sturfelt G, Segelmark M. Selga D, et al. Among authors: segelmark m. Rheumatology (Oxford). 2006 Oct;45(10):1276-81. doi: 10.1093/rheumatology/kel091. Epub 2006 Apr 4. Rheumatology (Oxford). 2006. PMID: 16595516

8

Increased neutrophil membrane expression and plasma level of proteinase 3 in systemic vasculitis are not a consequence of the - 564 A/G promotor polymorphism.

Abdgawad M, Hellmark T, Gunnarsson L, Westman KW, Segelmark M. Abdgawad M, et al. Among authors: segelmark m. Clin Exp Immunol. 2006 Jul;145(1):63-70. doi: 10.1111/j.1365-2249.2006.03119.x. Clin Exp Immunol. 2006. PMID: 16792675 Free PMC article.

9

The challenge of managing patients with polyarteritis nodosa.

Segelmark M, Selga D. Segelmark M, et al. Curr Opin Rheumatol. 2007 Jan;19(1):33-8. doi: 10.1097/BOR.0b013e328011cb6f. Curr Opin Rheumatol. 2007. PMID: 17143093 Review.

10

[Towards evidence-based therapy in primary systemic vasculitis. Progress during the past decades have improved the situations of today's patients].

Segelmark M, Westman K. Segelmark M, et al. Lakartidningen. 2007 Mar 21-27;104(12):954-7. Lakartidningen. 2007. PMID: 17469311 Review. Swedish. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

222 results

Search Page

Filters